IceCure is a proud exhibitor at the 2024 Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Conference in Lisbon, Portugal from September 14 – 18.
Are you attending CIRSE 2024? Visit us at Booth 15. Complete the contact us form on this page and schedule a meeting with IceCure!
IceCure Medical is committed to offering interventional radiologists the choice of cryoablation for optimal tumor destruction with our liquid nitrogen-based ProSense™ Cryoablation System. We will have live demonstrations, an exciting “Cryo Quiz” and presentation led by Prof. Julien Frandon, and participation in the hands-on device cold ablation sessions.
IceCure Activities at CIRSE 2024
- Meet Prof. Frandon & Take our Cryo Quiz – on Monday, September 16 at 11 AM CEST join IceCure and expert ProSense user, Professor Julien Frandon of CHU de Nimes, for cryoablation case presentations. Think you know all there is to know about liquid nitrogen cryoablation? See if you have what it takes to participate in our Cryo Quiz and test your knowledge!
- Hands-on Cold Ablation Sessions – Ready to get your hands-on a ProSense? Come witness the power of liquid nitrogen cryoablation at the CIRSE hands-on cold ablation sessions lead by expert ProSense users and the IceCure team. For more details on participation, visit the CIRSE website.
- Tuesday, September 17 from 8:30 – 10:00 CEST
- Tuesday, September 17 from 11:15 – 12:15 CEST
- Tuesday, September 17 from 13:00 – 14:30 CEST
- Learn about the ICE3 trial on cryoablation of small, low-risk breast cancer with a recurrence free rate of 96.3% for patients treated with ProSense and hormone therapy the results are promising for a new hope in the treatment of breast cancer. *
Looking forward to see you in Lisbon!
*The breast cancer indication for the ProSense® System is currently under review by the FDA and has not yet received marketing clearance in the US. ProSense™ is cleared for the treatment of breast cancer in the EU and other select markets. Clinical indications vary by region, please contact us for additional details.